OBJECTIVES The aim of our study was to investigate coronary vascular kinin
receptor function in patients with atherosclerosis or its risk factors.
BACKGROUND Although acetylcholine (ACH) is used as a probe for testing vasc
ular function in vivo, endogenous bradykinin (BK) regulates resting and flo
w-mediated epicardial tone.
METHODS In 53 patients with mild atherosclerosis or its risk factors and 9
control subjects, endothelium-dependent vasomotion was tested with intracor
onary ACH (30 mug/min) and BK (62.5 ng/min and 4 mug/min), and endothelium
independent function with sodium nitroprusside. Metabolic vasodilation was
assessed during cardiac pacing (n = 19). Correlation with serum angiotensin
-converting enzyme (ACE) levels and the ACE insertion/deletion genotype was
performed.
RESULTS There was progressive impairment in AGH-mediated microvascular dila
tion with increasing numbers of risk factors (p = 0.025, analysis of varian
ce). By contrast, BK- and sodium nitroprusside-mediated microvascular dilat
ion was similar in all groups. Similarly, there was no correlation between
epicardial coronary responses to ACH and BK; segments that constricted or d
ilated with ACH had similar dilator responses with BK. Bradykinin, but not
ACH-mediated vasomotion, was depressed in epicardial segments that constric
ted with pacing. Finally, epicardial BK responses were depressed in patient
s with high ACE levels and in those with the ACE DD genotype.
CONCLUSIONS Endothelial dysfunction in atherosclerosis appears to be recept
or-specific, involving the muscarinic receptor with relative sparing of the
kinin receptor pathways. Abnormal reactivity of epicardial coronary arteri
es during physiologic stress is better represented by BK and not by ACH res
ponses. Bradykinin activity and, hence, physiologic coronary vasomotion app
ears to be influenced by serum ACE levels and the ACE insertion/deletion ge
notype. (C) 2000 by the American College of Cardiology.